| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycoprotein(MW 180,000) ; Normal; 2500 ng/L(2.5 ng/mL) 1. concentrated in the Glycocalyx of epithelial Cells 2. released into the Lumen of the Bowel ; Malignancy 1. concentrations elevated in the Blood & other Body Fluids ; 1. Specific for Bowel Cancer 2. Nonspecific Tumor-associated Antigen 3. Benign Conditions ; Not selective for Cancer Not Used in Screening for Malignancy ; Sereal measurement; Treatments & the Recurrence of Disease - 의의(in Colon Ca) 1) F/U시 이용; Metastasis or recurrence 2) Metastasis 판정 3) Little Value in Dx - 증가하는 경우 1) Neoplasm(≥ 50 %) of 1> Colon 2> Pancreas 3> Lung 4> Breast 5> Stomach 2) Nonmalignant Conditions; Not over 10,000 ng/L(10ng/mL) 1> Cigarette Smoking 2> Chronic Pulmonary Disease 3> Liver Cirrhosis; Alcoholic 4> Hepatitis 5> Inflammatory Bowel Disease 6> Uremia |
|---|---|
| CEA | carcinoembryonic antigen; carotid endarterectomy; cholesterol-esterifying activity; cost-effectiveness analysis; crystalline egg albumin |
| CEAC | clinical education and assessment center |
| CEAL | carcinoembryonic antigen-like [protein] |
| CEAP | Clinical Efficacy Assessment Project [of ACP] |
| CEARP | Continuing Education Approval and Recognition Program |
| CEAT | chronic ectopic atrial tachycardia |